[Clinical characteristics of patients with chronic fatigue syndrome: analysis of 82 cases].
Li, Yong-Jie, Wang, De-Xin, Bai, Xiao-Li et al. · Zhonghua yi xue za zhi · 2005
Quick Summary
This study examined 82 Chinese patients with ME/CFS to understand what symptoms they experience and what might be causing their illness. Researchers found that most patients had memory and attention problems alongside fatigue, many showed signs of anxiety or depression, and some had low levels of a substance called L-carnitine (which helps produce energy) or evidence of a viral infection. When patients took L-carnitine supplements, their levels improved and symptoms got better.
Why It Matters
This study provides evidence that ME/CFS involves multiple biological abnormalities—including possible viral involvement (BDV), metabolic dysfunction (L-carnitine deficiency), and fatty acid dysregulation—rather than being purely psychological. The finding that L-carnitine supplementation improved symptoms offers a potential therapeutic target worth investigating further in larger, controlled trials.
Observed Findings
Cognitive impairment (memory/attention decline) was present in 84% of patients (69/82)
Psychological abnormalities on SCL-90 screening occurred in 70% of patients, with somatization most common (39%)
Anti-BDV-p24 antibodies were detected in 21% of CFS patients versus 0% of controls (p=0.010)
Plasma L-carnitine levels were significantly lower in CFS patients compared to healthy controls (6.43±3.42 vs 7.67±3.58, p=0.045)
L-carnitine supplementation for 2 weeks increased levels and was associated with symptom improvement
Inferred Conclusions
ME/CFS is a multifactorial condition involving psychological, infectious, and metabolic components rather than a single etiology
Some ME/CFS patients may have treatable L-carnitine deficiency that responds to supplementation
Borna disease virus infection may be present in a subset of ME/CFS patients and warrants further investigation
Cognitive dysfunction is a core feature of ME/CFS requiring clinical attention
Remaining Questions
What proportion of ME/CFS patients worldwide have BDV seropositivity, and does this correlate with disease severity or prognosis?
What This Study Does Not Prove
This study does not prove that BDV, L-carnitine deficiency, or fatty acid abnormalities are the primary cause of ME/CFS, only that they are associated with the condition in some patients. The cross-sectional design cannot establish causality or determine whether these abnormalities are causes or consequences of the illness. Results from a Chinese population may not generalize to other geographic or ethnic groups.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
What causes L-carnitine deficiency in ME/CFS—impaired synthesis, increased utilization, or malabsorption—and how many patients would benefit from supplementation?
Are the observed metabolic and immunological abnormalities specific to ME/CFS or also present in other fatiguing illnesses?
Which subsets of patients benefit from L-carnitine supplementation, and what is the optimal dosing and duration of treatment?